Application of Synthetic Biology Across Diverse Industries, Including Healthcare, to Bolster Its Demand & Absolute Opportunity
Not many companies manufacture synthetic biology products, due to which, the market for the same currently exhibits low competition. However, as synthetic biology products begin to gain traction, the entry of new players is expected. This, according to a new study by Transparency Market Research (TMR), will elevate the degree of competition prevailing in the global synthetic biology market. However, currently key players such as Amyris, Inc., DuPont, Inc., Royal DSM, Life Technologies Corporation, and Evolva Holding are spread across...
View full press release